RA'ANANA, Israel, Jan. 2, 2024 /PRNewswire/ -- Inspira Technologies OXY B.H.N Ltd. (Nasdaq: IINN) (Nasdaq: IINNW) (the 'Company' or 'Inspira Technologies'), a pioneer in life support technology with a vision to supersede traditional mechanical ventilators, has announced the signing of a non-binding Letter of Intent (LOI) with Northwestern Memorial Hospital in Chicago, Illinois ('Northwestern').

以色列拉阿纳纳，2024年1月2日/PRNewswire/-Inspira Technologies OXY B.H.N Ltd.（纳斯达克股票代码：IINN）（纳斯达克股票代码：IINNW）（“公司”或“Inspira Technologies”）是生命支持技术的先驱，旨在取代传统的机械呼吸机，已宣布与伊利诺伊州芝加哥西北纪念医院（“西北”）签署一份无约束力的意向书（LOI）。

Northwestern, ranked as the eighth best hospital in the United States by Newsweek in 2023, is part of Northwestern Medicine, which operates several hospitals in the United States.  .

西北医院是西北医学（Northwestern Medicine）的一部分，2023年被《新闻周刊》（Newsweek）评为美国第八大最佳医院，该医院在美国拥有多家医院。。

The LOI expresses the mutual interest by both parties to further explore potential collaboration regarding the evaluation of how the INSPIRA ART100 device ('Device' or 'Devices') aligns with Northwestern's needs in clinical scenarios, workflow efficiency, and healthcare delivery. Northwestern will also agree to purchase all necessary disposables to operate the Devices and will, in turn, provide Inspira Technologies with valuable data and Device diagnostics from its usage.

意向书表达了双方的共同兴趣，即在评估INSPIRA ART100设备（“设备”或“设备”）如何与西北大学在临床场景、工作流程效率和医疗保健服务方面的需求相一致方面，进一步探索潜在的合作。西北航空还将同意购买所有必要的一次性用品来操作这些设备，并将为Inspira Technologies提供有价值的数据和设备诊断。

The terms of the agreement contemplated by the LOI are subject to U.S. Food & Drug Administration ('FDA') clearance of the Device in the first half of 2024 as well as the parties entering a definitive evaluation agreement..

意向书预期的协议条款须在2024年上半年获得美国食品和药物管理局（“FDA”）的批准，以及签署最终评估协议的各方。。

Joe Hayon, President of Inspira Technologies, commented: 'We believe that an opportunity to evaluate the INSPIRA ART100 with a leading hospital, such as Northwestern, may evolve into a significant route to entering the healthcare market in the U.S.'

Inspira Technologies总裁乔·海恩（JoeHayon）评论道：“我们认为，有机会与西北等领先医院一起评估Inspira ART100，可能会成为进入美国医疗保健市场的重要途径。”

About Northwestern Memorial Hospital

西北纪念医院简介

Northwestern Memorial Hospital ('Northwestern'), based in Chicago, is a leading academic medical center. Northwestern has earned significant recognition on the U.S. News & World Report's 'America's Best Hospitals' list for 2023. Recognized as the seventh most prestigious institution in cardiology, heart & vascular Surgery and the eighteenth most prestigious institution in pulmonology & lung surgery, Northwestern is also a large lung transplant center.

位于芝加哥的西北纪念医院（“西北”）是一家领先的学术医疗中心。西北大学在《美国新闻与世界报道》（U.S.News&World Report）的2023年“美国最佳医院”名单上获得了重要认可。西北大学是一家大型肺移植中心，被公认为心脏病学、心脏和血管外科领域第七大最负盛名的机构，肺科和肺外科领域第十八大最负盛名的机构。

Northwestern achieved recognition as a Gold Level Extracorporeal Life Support Organization Center of Excellence..

西北大学被公认为黄金级体外生命支持组织卓越中心。。

Inspira Technologies OXY B.H.N Ltd.

Inspira Technologies OXY B.H.N有限公司。

Inspira Technologies is leading the way in transforming life-support care. Its innovative solutions are paving the way for direct blood oxygenation, bypassing the lungs, and potentially reducing the need for traditional mechanical ventilation. Beyond this, the Company is committed to advancing blood circulation technology and incorporating AI-driven monitoring systems.

Inspira Technologies正在引领生命支持护理的变革。它的创新解决方案正在为直接血氧合铺平道路，绕过肺部，并有可能减少对传统机械通气的需求。除此之外，该公司致力于推进血液循环技术，并纳入人工智能驱动的监测系统。

These advancements are part of its strategy to offer more patient-focused, data-informed care. The integration of these technologies signifies the potential to enhance patient outcomes and streamline hospital operations, marking a new era in respiratory care..

这些进步是其战略的一部分，旨在提供更多以患者为中心的数据知情护理。这些技术的整合意味着有可能提高患者的治疗效果并简化医院运营，标志着呼吸护理的新时代。。

For more information, please visit our corporate website:

有关更多信息，请访问我们的公司网站：

https://inspira-technologies.com/

https://inspira-technologies.com/

Forward-Looking Statement Disclaimer

前瞻性声明免责声明

This press release contains express or implied forward-looking statements under US Federal securities laws. These forward-looking statements and their implications are based only on the current expectations of the management of the Company. They are subject to several factors and uncertainties that could cause results to differ materially from those described in the forward-looking statements.

本新闻稿包含美国联邦证券法下的明示或暗示前瞻性声明。这些前瞻性陈述及其影响仅基于公司管理层当前的期望。它们受到多种因素和不确定性的影响，这些因素和不确定性可能导致结果与前瞻性声明中描述的结果存在重大差异。

For example, the Company uses forward-looking statements when it discusses the Company's vision to supersede traditional mechanical ventilators, the anticipated FDA clearance of its INSPIRA ART100, the prospective mutually beneficial outcomes of the LOI, including Northwestern's commitment to purchase all necessary disposables to operate the Devices,  the belief that this LOI may evolve into a significant route to entering the healthcare market in the U.S., and that it intends to enter into a definitive agreement with Northwestern.

例如，该公司在讨论公司取代传统机械呼吸机的愿景时，使用了前瞻性陈述，预期FDA会批准其INSPIRA ART100，意向书的预期互利结果，包括西北航空公司承诺购买所有必要的一次性用品来操作这些设备，相信该意向书可能会成为进入美国医疗保健市场的重要途径，并打算与西北大学签订最终协议。

Inspira and Northwestern may not ultimately reach an agreement on definitive terms as a result of signing the non-binding LOI described herein and the cooperation contemplated herein may not occur. Except as otherwise required by law, the Company undertakes no obligation to publicly release any revisions to these forward-looking statements to reflect events or circumstances after the date hereof or the occurrence of unanticipated events.

由于签署了本文所述的不具约束力的意向书，Inspira和Northwestern可能无法最终就最终条款达成协议，并且可能不会进行本文所述的合作。除非法律另有要求，否则公司没有义务公开发布对这些前瞻性声明的任何修订，以反映本协议日期后的事件或情况或意外事件的发生。

More detailed information about the risks and uncertainties affecting the Company is contained under the heading 'Risk Factors' in the Company's annual report on Form 20-F for the fiscal year ended December 31, 2022, filed with the SEC, which is available on the SEC's website, www.sec.gov..

有关影响公司的风险和不确定性的更多详细信息，请参阅公司截至2022年12月31日财年的20-F表年度报告中的“风险因素”标题，该报告已提交给SEC，可在SEC网站www.SEC.gov上查阅。。

For more details:Public Relations ManagerAdi ShmueliInspira Technologiesinfo@inspirao2.com+972-9-9664485

更多详情：公共关系经理Radi ShmuelispiraTechnologiesinfo@inspirao2.com+972-9-9664485

Copyright © 2018-2023 Inspira Technologies OXY B.H.N. LTD., All rights reserved.

版权所有©2018-2023 Inspira Technologies OXY B.H.N.LTD.，保留所有权利。

SOURCE Inspira Technologies

源Inspira Technologies